Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.29 | -44.44 |
| PEG Ratio (TTM) | -1.81 | -0.02 |
| P/S Ratio (TTM) | 0.74 | 1.25 |
| P/B Ratio (TTM) | 1.41 | 2.74 |
| P/FCF Ratio (TTM) | 8.16 | 14.59 |
| Price to 5YR AVG Earnings Ratio | 19.33 | -16.75 |
| Price to 5YR AVG FCF Ratio | -22.79 | -25.16 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.80% | 0.28% |
| ROE (TTM) | 8.37% | 12.99% |
| Net Profit Margin (TTM) | 4.25% | -2,254.18% |
| ROIC 5YR AVG | 4.85% | 3.04% |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 118.84% | 741.28% | 492.86% |
| Revenue | 1.31% | 10.95% | 18.75% |
| Net Income | 108.58% | 717.68% | 476.63% |
| Cash Flow | 281.30% | 13,562.38% | 8,141.53% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.59 | 1.68 |
| Quick Ratio (TTM) | 0.57 | 1.63 |
| D/E Ratio (TTM) | 0.64 | 1.04 |
| Interest Coverage (TTM) | 2.18 | 3.94 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 1.32 | 2.82 |
| LTL to 5YR AVG FCF | -16.83 | 12.97 |
| Shares Outstanding Growth 5YR AVG | -0.53% | 57.71% |